261 related articles for article (PubMed ID: 1427974)
1. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
Benson JL; Niederkorn JY
Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
3. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition".
Niederkorn JY; Mayhew E; He Y
Transplantation; 1995 Aug; 60(4):348-54. PubMed ID: 7652764
[TBL] [Abstract][Full Text] [Related]
4. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
Li XY; Niederkorn JY
Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
[TBL] [Abstract][Full Text] [Related]
5. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
6. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
7. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
Li XY; D'Orazio LT; Niederkorn JY
Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
9. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
Skelsey ME; Mellon J; Niederkorn JY
J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
[TBL] [Abstract][Full Text] [Related]
10. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
11. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation.
Niederkorn JY
Transplantation; 1987 Apr; 43(4):523-8. PubMed ID: 2953091
[TBL] [Abstract][Full Text] [Related]
12. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
[TBL] [Abstract][Full Text] [Related]
13. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts.
Slegers TP; van der Gaag R; van Rooijen N; van Rij G; Streilein JW
Curr Eye Res; 2003 Feb; 26(2):73-9. PubMed ID: 12815525
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
[TBL] [Abstract][Full Text] [Related]
15. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
Williamson JS; Streilein JW
Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
[TBL] [Abstract][Full Text] [Related]
16. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation.
Williamson JS; Streilein JW
Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700
[TBL] [Abstract][Full Text] [Related]
17. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
Koevary SB; Beaudry K
Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.
Sakai R; Yamagami S; Inoki T; Tsuru T; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):154-9. PubMed ID: 11931082
[TBL] [Abstract][Full Text] [Related]
19. Anterior chamber-associated immune deviation promotes corneal allograft survival.
Niederkorn JY; Mellon J
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
[TBL] [Abstract][Full Text] [Related]
20. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
D'Orazio TJ; Niederkorn JY
Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
